Plain-English translation of NCT05373043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether exercise rehabilitation—with or without a supplement called Mito-Q—can help people recover from long-COVID symptoms that linger months after infection. Researchers believe that COVID-19 damages blood vessels in ways that cause persistent fatigue, weakness, and cognitive problems in about 30-40% of patients, and they want to see if targeted exercise and this antioxidant supplement can repair that damage and speed recovery.
Many people experience long-lasting symptoms after COVID-19, but doctors don't yet have proven treatments to help them recover faster. This study exists to understand why some people struggle with long-COVID and whether this treatment approach can reduce those lingering symptoms and improve overall health.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either an exercise program alone or an exercise program combined with daily Mito-Q supplementation. Both groups will participate in structured rehabilitation focused on improving blood vessel function and overall fitness. The study will track your symptoms, blood vessel health, and recovery over time through various tests and visits.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States